EA201991910A1 - TRICYCLIC CONNECTION AND WAYS OF ITS APPLICATION - Google Patents

TRICYCLIC CONNECTION AND WAYS OF ITS APPLICATION

Info

Publication number
EA201991910A1
EA201991910A1 EA201991910A EA201991910A EA201991910A1 EA 201991910 A1 EA201991910 A1 EA 201991910A1 EA 201991910 A EA201991910 A EA 201991910A EA 201991910 A EA201991910 A EA 201991910A EA 201991910 A1 EA201991910 A1 EA 201991910A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ways
tricyclic
connection
application
hbv
Prior art date
Application number
EA201991910A
Other languages
Russian (ru)
Other versions
EA038176B9 (en
EA038176B1 (en
Inventor
Хайин Хэ
Цзин ВАН
Чжигань ЦЗЯН
Ясюнь Ян
Пэн Шао
Чэнь ЧЖАН
Цзянь Ли
Шухуэй Чэнь
Original Assignee
Фуцзянь Косантер Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фуцзянь Косантер Фармасьютикал Ко., Лтд. filed Critical Фуцзянь Косантер Фармасьютикал Ко., Лтд.
Priority claimed from PCT/CN2018/075995 external-priority patent/WO2018153285A1/en
Publication of EA201991910A1 publication Critical patent/EA201991910A1/en
Publication of EA038176B1 publication Critical patent/EA038176B1/en
Publication of EA038176B9 publication Critical patent/EA038176B9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

В настоящем изобретении раскрыты соединение, представленное формулой (I), его таутомер или фармацевтически приемлемая соль и пути их применения в получении лекарственных средств, предназначенных для лечения связанных с HBV заболеваний.The present invention discloses a compound represented by formula (I), a tautomer or a pharmaceutically acceptable salt thereof, and ways of using them in the preparation of medicaments for the treatment of HBV-related diseases.

EA201991910A 2018-01-04 2018-02-09 Pyrrolo[1,2,5]benzothiadiazepine derivatives and use thereof in treating a disease caused by hepatitis b virus EA038176B9 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810008592 2018-01-04
PCT/CN2018/075995 WO2018153285A1 (en) 2017-02-23 2018-02-09 Tri-cycle compound and applications thereof

Publications (3)

Publication Number Publication Date
EA201991910A1 true EA201991910A1 (en) 2020-01-23
EA038176B1 EA038176B1 (en) 2021-07-19
EA038176B9 EA038176B9 (en) 2021-09-07

Family

ID=69374475

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991910A EA038176B9 (en) 2018-01-04 2018-02-09 Pyrrolo[1,2,5]benzothiadiazepine derivatives and use thereof in treating a disease caused by hepatitis b virus

Country Status (1)

Country Link
EA (1) EA038176B9 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102060786A (en) * 2011-01-20 2011-05-18 天津大学 4-(substituted-1,3-diyne)-4-(trifluoromethyl)-3,4-dihydro substituted quinazoline-2-ketone compound as well as preparation method and application thereof
HUE033542T2 (en) * 2013-04-03 2017-12-28 Janssen Sciences Ireland Uc N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
CA2928003A1 (en) * 2013-11-14 2015-05-21 Novira Therapeutics, Inc. Azepane derivatives and methods of treating hepatitis b infections
RU2016146365A (en) * 2014-05-13 2018-06-19 Ф. Хоффманн-Ля Рош Аг NEW DIHYDROCHINOLYSINE FOR THE TREATMENT AND PREVENTION OF HEPATITIS B VIRUS INFECTION

Also Published As

Publication number Publication date
EA038176B9 (en) 2021-09-07
EA038176B1 (en) 2021-07-19

Similar Documents

Publication Publication Date Title
EA201991693A1 (en) PYRIDINE DERIVATIVE AS ASK1 INHIBITOR AND METHOD FOR PRODUCING AND USE
SA519402405B1 (en) Human immunodeficiency virus inhibitor compounds
ZA202006378B (en) N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
EA202090530A1 (en) 1-BENZYL-2-IMINO-4-PHENYL-5-OXOIMIDAZOLIDINE DERIVATIVES AS HIV PROTEASE INHIBITORS
SG11201809859VA (en) Benzazepine derivative, preparation method, pharmaceutical composition and use thereof
EA201890654A1 (en) THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF THE HUMAN IMMUNODEFICIENCY VIRUS
EA201890200A1 (en) DERIVATIVES OF CYCLIZED SULFAMOILARILAMIDE AND THEIR APPLICATION AS A MEDICINE PREPARATION FOR THE TREATMENT OF HEPATITIS B
EA202090688A1 (en) BIS-AMIDE CONNECTIONS ACTIVATING SARCOMER AND VARIANTS OF THEIR APPLICATION
PH12019501955A1 (en) Tri-cycle compound and applications thereof
EA201591457A1 (en) THERAPEUTIC CONNECTIONS
MX2019002541A (en) Anti-influenza virus pyrimidine derivative.
MD3416631T2 (en) Therapeutic agents for neurodegenerative diseases
CY1124251T1 (en) CARBOXAMIDE DERIVATIVES
CL2024000067A1 (en) Antiviral compounds
EA201992771A1 (en) HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR
EA202192512A1 (en) FUSED RING PYRIMIDONE DERIVATIVES FOR USE IN THE TREATMENT OF HBV INFECTION OR HBV DISEASES
MX2021015056A (en) Pyrrolopyrimidine compound and use thereof.
MX2021012105A (en) Pyrrole compounds.
EA201692298A1 (en) DERIVATIVES OF CARBOXAMIDES
MX2020013297A (en) Compound for treatment or prevention of liver diseases.
PH12020552186A1 (en) Cyanotriazole compounds and uses thereof
EA202190316A1 (en) CONDENSED LACTAM DERIVATIVE
EA201792264A1 (en) METHODS OF TREATING INFLAMMATORY DISEASES
EA202190398A1 (en) CONDENSED RING DERIVATIVE USED AS FGFR4 INHIBITOR
EA201691058A1 (en) DERIVATIVES OF PYRROLOPIRROLON AND THEIR APPLICATION FOR THE TREATMENT OF DISEASES

Legal Events

Date Code Title Description
TH4A Publication of the corrected specification to eurasian patent